Dr. Richard Lester is an Infectious Diseases physician, Associate Professor at the University of British Columbia, Canada, and Co-Founder of WelTel Health (
www.weltelhealth.com), a digital health social enterprise. He led the
WelTel Kenya1 trial, providing the world’s first evidence that direct patient text messaging could improve treatment outcomes for HIV/AIDS patients starting antiretroviral therapy (ART) in Kenya. Supported by PEPFAR and published in
The Lancet in 2010, this trial helped pioneer mobile health innovation.
WelTel’s patient follow-up and engagement service has since expanded globally, supporting patients with HIV, TB, chronic and non-chronic diseases, mental health challenges, and maternal and newborn child health (MNCH) in Africa, Canada, the United States, New Zealand, and Peru.
In 2020, the Government of Rwanda adopted WelTel to support outpatients through the national COVID-19 Home-Based Care program, later extending its use to Ebola response. WelTel is now a registered company in Rwanda.
Dr. Lester is a Member of the Roster of Experts for the World Health Organization Digital Health Task Force and was recognized as Digital Health Canada’s Clinical Innovator of the Year in 2020. WelTel remains dedicated to improving outcomes and saving lives for all — including women, children, and vulnerable populations — ensuring no one is left behind.